Загрузка видео...

Не удалось загрузить видео

На главную

Dr. David Campbell from UCalgaryMedicine and community co-researcher, Brian Bowridge, share the story behind Low, a film based on lived experience and research from the Calgary Diabetes Advocacy Committee The Campbell Lab Libin Cardiovascular Institute Department of Medicine #UCalgary

155,314 просмотров • 2 лет назад •via X (Twitter)

Комментарии: 1

Фото профиля Katherine Mathews
Katherine Mathews2 лет назад

@UCalgaryMed @CampbellLab_yyc @LibinInstitute @CalDomMed How do we see the movie or the film?

Похожие видео

Today, more than 170 delegates from all 50 states and five countries were in Washington for the 2025 Breakthrough Type 1 Diabetes Children’s Congress. I was proud to chair a Senate Appropriations Committee hearing to welcome the delegates and focus on the importance of federal investment in Type 1 diabetes research. Senator Jeanne Shaheen and I — the founding co-chairs of the bipartisan Senate Diabetes Caucus — introduced legislation this week to reauthorize the Special Diabetes Program, a federal initiative that provides $160 million annually for Type 1 diabetes research and prevention. Thanks to this program and the tireless advocacy of Breakthrough T1D and its Children’s Congress Delegates, we are seeing life changing breakthroughs in the fight against this terrible disease. Some of these developments include the now widely used continuous glucose monitors, the first FDA-approved artificial pancreas, and a groundbreaking clinical trial in which 10 of the 12 participants no longer need insulin to manage their diabetes because of a stem cell-based therapy. Since the founding of the Senate Diabetes Caucus in 1997, federal funding for diabetes research has increased from $319 million to more than $2.3 billion annually. I want to thank our outstanding witnesses for today’s hearing: Ruby Whitmore of Old Town, Maine, Rachel White of North Hampton, New Hampshire, Katie Bone of Bernalillo, New Mexico, and Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Their passionate testimony highlighted both the daily realities of living with type 1 diabetes and the vital role of continued federal research through agencies like the NIDDK. Finding a cure for Type 1 diabetes remains our ultimate goal and has been one of my highest priorities since the very beginning of my Senate service. With continued advocacy, bipartisan support, and strong federal investment, I am confident that day will come.

Sen. Susan Collins

12,348 просмотров • 1 год назад